search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
DISCOVER


THE NEXT WAVE OF IMMUNE CELL ANALYSIS


Detect Immune Cell Activation in Real Time with Agilent Seahorse XF Technology


Don’t wait hours for immune cell activation results. Agilent Seahorse XF technology detects activation within minutes of stimulation by measuring discrete changes in cellular bioenergetics in live cells, in real time. Rapid detection opens a window to the earliest events of immune cell activation, enabling researchers to identify changes in activation kinetics and the magnitude of activation.


Accelerate immune cell activation analysis from hours to minutes Modulate activation with integrated compound injection ports Investigate immune cell metabolism through standardized assays and software


Learn more about Agilent Seahorse XF products and immune cell analysis at www.agilent.com/chem/immunology


T cell Activation Assay using naïve T cells


Injection of anti-CD3 and anti-CD28 beads


30 20 Vehicle 10 0 0 50 100 Time (minutes)


For Research Use Only. Not for use in diagnostic procedures. © Agilent Technologies, Inc. 2018


150 anti-CD3/CD28 Baseline Activated 300 200 100


LPS+ INF Control


0 0 50 100 Time (minutes) 150


Macrophage Activation Assay using polarized M1 macrophages


LPS Injection Baseline Activated


ECAR (mpH/min)


PER (pmol/min)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72